Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Radical -xh acid – or anhydride – acid halide or salt thereof...
Reexamination Certificate
2002-07-03
2009-02-17
Shiao, Rei-tsang (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Radical -xh acid, or anhydride, acid halide or salt thereof...
C560S009000, C435S141000
Reexamination Certificate
active
07491747
ABSTRACT:
The present invention relates to a compound of the formula I: (Formula I) in which: A, B, R1, Z, n and R2are as defined in claim1. These compounds are useful in the treatment of dyslipidaemia, atherosclerosis and diabetes.
REFERENCES:
patent: 6013649 (2000-01-01), Freskos et al.
patent: 6100266 (2000-08-01), Baxter et al.
patent: 2001/0008947 (2001-07-01), Varasi et al.
patent: 2002/0103239 (2002-08-01), Bedell et al.
patent: 2161991 (1973-06-01), None
patent: P9501146 (1995-10-01), None
patent: P9902437 (1999-12-01), None
patent: 02-193942 (1990-07-01), None
patent: WO 9803164 (1998-01-01), None
patent: WO 9839316 (1998-09-01), None
Expert Opinion, vol. 11(3), pp. 379-401, 2006.
Patent Abstracts of Japan vol. 1997, No. 09, Sep. 30, 1997 & JP 09136873 A (Fuji Chemical Industry), May 27, 1997 abstract.
Patent Abstracts of Japan vol. 2000, No. 14, Mar. 5, 2001 & JP 2000309573 A (Fuji Chemical Industry), Nov. 7, 2000 abstract.
M. Terada, et al.: “Enantiomerically pure compound synthesis by asymmetric glyoxylate-ene reaction with vinylic sulphides and selenides catalysed by a chiral titanium complex” Journal of the Chemical Society, Chemial Communications, No. 3, Feb. 7, 1993, pp. 327-328, XP002195871.
D. C. Lathbury, et al.: “ A route to the pyrrolizidone ring system using a novel radical cyclisation” Journal of the Chemical Society, Chemial Communications, No. 2, Jan. 15, 1988, pp. 81-82, XP002195872.
T. Konno, et al.: “Synthesis and application of a alpha-trifluoromethylated aldehydes” Tetrahedron, vol. 52, No. 1, Jan. 1, 1996 pp. 199-208, XP004104597.
P. Renaud , et al.: “Use of O, Se-acetals for radical-mediated phenylseleno group transfer reactions” Synthesis, No. 2, Feb. 1996, pp. 253-258, XP002195873.
Y. Gao, et al.: “Stereoselective synthesis of meso-2,6-diaminopimelic acid and its selectively protected derivatives” Journal of Organic Chemsitry, vol. 63, No. 7,Apr. 3, 1998 pp. 2133-2143 XP002195874.
L.J. Jolivette, et al.: “Thietanium ion formation from the food mutagen 2-chloro-4-(methylthio)butanoic acid” Chemical Research in Toxicology, vol. 11, No. 7, May 30, 1998 pp. 794-799, XP002195875.
A.K. Ghosh, et al.: “Synthetic studies of antitumour macrolide laulimalide: a stereoselective synthesis of the C17-C28 segment” Tetrahedron Letters, vol. 41, No. 24, Jun. 2000 pp. 4705-4708 XP004205603.
E. Yoshii, et al.: “Introduction of a 3-alkoxycarbonyl-2-propenyl group at the ortho position of phenol and naphthol via alpha-aryloxy-gamma-butyrolactone. Application to synthesis of (+−)-nanaomycin A and a 1-anthracenone” Chemical and Pharmaceutical Bulletin, vol. 32, No. 12, Dec. 1984 pp. 4779-4785, XP002195877.
J.-G. Boiteau, et al.: “A new, ring closing metathesis-based synthesis of (−)-fumagillol” Organic Letters, vol. 3, No. 17, Jul. 31, 2001 pp. 2737-2740, XP002195876.
Berthelon Jean-Jacques
Contard Francis
Didier Roche
Dupont Herve
Guerrier Daniel
Chung Susannah
Merck Patent GmbH
Millen White Zelano & Branigan P.C.
Shiao Rei-tsang
LandOfFree
Butyric acid derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Butyric acid derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Butyric acid derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4100323